Closed Solicitation · DEPT OF DEFENSE
AI Summary
The Department of Defense is seeking market research responses for a barrier combination product aimed at battlefield wound infection prevention and treatment. This RFI focuses on developing medical products suitable for austere environments. Interested parties must submit their responses by January 20, 2026, at 2:00 PM Eastern. Please refer to the attached documents for detailed requirements.
The Government is conducting market research to determine whether a commercial solution can be provided to meet requirements for battlefield wound infection prevention and treatment: barrier combination product. This market research may also assist with the further development and/or refinement of the requirements. Objective and Purpose/Scope: DHAs OPMED WPAC has a requirement to develop, deliver, and field medical products that address battlefield wounds and subsequent bacterial and fungal infections. The Battlefield Wound Infection Prevention and Treatment (BWI P&T) program is using a Family of Systems (FoS) approach that aims to develop multiple medical materiel solutions that are most relevant for use in austere environments where medical products may be limited and evacuation may be prolonged. This RFI seeks responses to the barrier combination component of this FoS only. Although there is an emphasis on use at the point of injury, this capability will likely be used across roles of care spanning the austere battlefield environment to hospital care settings. The barrier combination product is expected to be one of many components of the FoS that will provide novel solutions to the DoD and commercial market with respect to wound care and infection prevention. The barrier combination product must have the following minimum essential characteristics: Please refer to Attachment 3 - Minimum Essential Characteristics (MECS) North American Industry Classification System (NAICS) Code: Unknown RFI Attachments: The following documents are attached to the RFI Attachment 1: Technical Readiness Level (TRL) (Reference Only) Attachment 2: Company & Product Information Attachment 3: Minimum Essential Characteristics (MECS) Response Due Date: Interested parties shall submit the RFI response electronically by 2:00pm Eastern on January 20, 2026, via e-mail to: Please review Attachments 1, 2, and 3 as well as RFI for BWI PT Barrier Attachment for further instructions
BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.